首页> 外国专利> The therapeutical composion for diabetes from Lentinus edodes exo-polymer produced from submerged mycelial culture and method for isolation thereof

The therapeutical composion for diabetes from Lentinus edodes exo-polymer produced from submerged mycelial culture and method for isolation thereof

机译:淹没菌丝培养物生产的香菇外来聚合物对糖尿病的治疗组合及其分离方法

摘要

The invention reduces, streptozotocin induced an extracellular polysaccharide produced by the diabetic rats from the mycelium liquid culture of mushroom is the level of plasma glucose compared to the control related to a diabetes therapeutic composition of the mushroom stems extent of 21.5% and it has a superior effect of increasing the concentration of plasma insulin. In addition, there is the excellent effect of lowering total cholesterol and triglyceride content of 25.1 and 44.5% respectively of the plasma. Therefore, an extracellular polysaccharide of mushroom origin is very useful inventions the pharmaceutical industry since the hypoglycemic effect it is possible to provide for excellent treatment of diabetes to the extracellular polysaccharide, as an active ingredient composition.
机译:本发明减少了链脲佐菌素诱导的糖尿病大鼠从蘑菇菌丝体液体培养物中产生的细胞外多糖的血浆葡萄糖水平,与与蘑菇茎的糖尿病治疗组合物有关的对照相比为21.5%,并且具有优越的增加血浆胰岛素浓度的效果。另外,具有降低血浆中总胆固醇和甘油三酸酯含量分别为25.1和44.5%的出色效果。因此,蘑菇来源的细胞外多糖在制药工业中是非常有用的发明,因为降血糖作用可以为细胞外多糖作为有效成分组合物提供出色的糖尿病治疗。

著录项

  • 公开/公告号KR100475444B1

    专利类型

  • 公开/公告日2005-03-10

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20020009982

  • 申请日2002-02-25

  • 分类号C08B37/00;

  • 国家 KR

  • 入库时间 2022-08-21 22:04:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号